MRBEE: A novel bias-corrected multivariable Mendelian Randomization method

• Published in: bioRxiv
• Main Authors: Lorincz-Comi, Noah, Yang, Yihe, Li, Gen, Zhu, Xiaofeng
• Format: Journal Article Paper
• Language: English
• Published: United States Cold Spring Harbor Laboratory Press 12.06.2023; Cold Spring Harbor Laboratory
• Edition: 1.3
• Subjects: Blood pressure; Cannabis; Cardiovascular disease; Coronary artery disease; Genomes; Genomics; Heart diseases; Mental disorders; Risk factors; Schizophrenia; Statistical analysis; Mendelian Randomization; Statistical Genetics; Complex Disease; Genetic Epidemiology
• ISSN: 2692-8205; 2692-8205
• DOI: 10.1101/2023.01.10.523480

Mendelian randomization (MR) is an instrumental variable approach used to infer causal relationships between exposures and outcomes and can apply to summary data from genome-wide association studies (GWAS). Since GWAS summary statistics are subject to estimation errors, most existing MR approaches suffer from measurement error bias, whose scale and direction are influenced by weak instrumental variables and GWAS sample overlap, respectively. We introduce MRBEE (MR using Bias-corrected Estimating Equation), a novel multivariable MR method capable of simultaneously removing measurement error bias and identifying horizontal pleiotropy. In simulations, we showed that MRBEE is capable of effectively removing measurement error bias in the presence of weak instrumental variables and sample overlap. In two independent real data analyses, we discovered that the causal effect of BMI on coronary artery disease risk is entirely mediated by blood pressure, and that existing MR methods may underestimate the causal effect of cannabis use disorder on schizophrenia risk compared to MRBEE. MRBEE possesses significant potential for advancing genetic research by providing a valuable tool to study causality between multiple risk factors and disease outcomes, particularly as a large number of GWAS summary statistics become publicly available.